$CNMD News

B of A Securities Maintains Neutral on Conmed, Lowers Price Target to $40

Wells Fargo Maintains Equal-Weight on Conmed, Lowers Price Target to $39

JP Morgan Maintains Neutral on Conmed, Lowers Price Target to $40

CONMED Corporation 2026 Q1 - Results - Earnings Call Presentation

CONMED Corporation (CNMD) Q1 2026 Earnings Call Transcript

CONMED Corporation (NYSE:CNMD) Beats Q1 Estimates and Raises Revenue Guidance, Shares Steady

Conmed Raises FY2026 Sales Guidance from $1.345B-$1.375B to $1.350B-$1.375B vs $1.359B Est

Conmed Q1 Adj. EPS $0.89 Beats $0.82 Estimate, Sales $317.046M Beat $310.507M Estimate

Q4 Earnings Highs And Lows: CONMED (NYSE:CNMD) Vs The Rest Of The Surgical Equipment & Consumables - Diversified Stocks

Could CONMED’s Q4 Beat and Q1 Preview Reframe Its Margin Narrative for CNMD Investors?

Is It Time To Revisit CONMED (CNMD) After A 37% One Year Share Price Slide?

CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026

Are Options Traders Betting on a Big Move in CONMED Stock?

Micro-Tech Endoscopy Signs Definitive Agreement to Acquire Duraclip™, Precisor®, and Optibite® Product Lines from CONMED

Piper Sandler Downgrades CONMED (CNMD)

A Look At CONMED (CNMD) Valuation After Recent Weak Share Price Momentum

CONMED Earnings Reset Story After Strong Quarter And Higher Guidance

3 Reasons CNMD is Risky and 1 Stock to Buy Instead

Conmed (CNMD) Up 22.9% Since Last Earnings Report: Can It Continue?

5 Must-Read Analyst Questions From CONMED’s Q4 Earnings Call